Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma
Authors
Keywords
-
Journal
LEUKEMIA
Volume 28, Issue 9, Pages 1902-1908
Publisher
Springer Nature
Online
2014-02-18
DOI
10.1038/leu.2014.75
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load
- (2013) Kai Neben et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of primary molecular cytogenetic abnormalities and risk of progression in smoldering multiple myeloma
- (2013) S V Rajkumar et al. LEUKEMIA
- Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging “early myeloma”
- (2013) Jens Hillengass et al. LEUKEMIA & LYMPHOMA
- Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
- (2013) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: A single center experience on 228 patients
- (2012) Lia A. Moulopoulos et al. AMERICAN JOURNAL OF HEMATOLOGY
- Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma
- (2012) J. Hillengass et al. HAEMATOLOGICA
- Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease
- (2012) E Kastritis et al. LEUKEMIA
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies
- (2011) N. Korde et al. BLOOD
- Advances in Imaging and the Management of Myeloma Bone Disease
- (2011) Evangelos Terpos et al. JOURNAL OF CLINICAL ONCOLOGY
- Current and future imaging modalities for multiple myeloma and its precursor states
- (2011) Esther Tan et al. LEUKEMIA & LYMPHOMA
- Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
- (2010) Jens Hillengass et al. JOURNAL OF CLINICAL ONCOLOGY
- Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
- (2010) R A Kyle et al. LEUKEMIA
- Smoldering (Asymptomatic) Multiple Myeloma: Current Diagnostic Criteria, New Predictors of Outcome, and Follow-Up Recommendations
- (2009) Joan Bladé et al. JOURNAL OF CLINICAL ONCOLOGY
- International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
- (2009) M Dimopoulos et al. LEUKEMIA
- Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging
- (2009) Tobias Bäuerle et al. RADIOLOGY
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
- (2007) A. Dispenzieri et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now